Mad Money Uncovered...
Health Care: Drugs
Zogenix Inc. (ZGNX: NASDAQ)
$1.57 -0.03 | -1.88%
05/20/13 - 03:59 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| ZGNX | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 9.59 | -12.09 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 18.00 | 0.00 | 0.00 |
| Net Income | 0.03 | 0.00 | |
| EPS | -0.87 | 0.00 |
Earnings for ZGNX:
| EBITDA | -43.00 |
| REVENUE | 44.33M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.14 | $-0.14 | $-0.61 | $-0.36 |
| Number of Analysts | 5 | 5 | 5 | 5 |
| High Estimate | $-0.13 | $-0.12 | $-0.53 | $-0.16 |
| Low Estimate | $-0.17 | $-0.15 | $-0.67 | $-0.52 |
| Prior Year | $-0.26 | $-0.15 | $-0.72 | $-0.61 |
| Growth Rate (Year over Year) | 44.62% | 9.33% | 15.00% | 40.85% |
Portfolios with ZGNX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserMy stocks
- UserJaheer
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
Latest ZGNX Headlines from TheStreet
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Zogenix And Battelle Extend DosePro Co-Marketing Partnership 03.27.13 | 08:03 am
- Zogenix Reports Fourth Quarter And Full Year 2012 Financial Results 03.15.13 | 07:03 am
- Zogenix Announces Conference Call And Webcast To Present Fourth Quarter And Full Year 2012 Financial Results 03.07.13 | 07:03 am
- Zogenix Provides Update On Zohydro(TM) ER Regulatory Review 02.26.13 | 08:02 pm
- 5 Stocks Under $10 Set to Explode 02.14.13 | 01:02 pm
- Zogenix Announces Preliminary Fourth Quarter 2012 Gross Product Sales 01.07.13 | 07:01 am
- Zogenix Reports Positive Results From Relday(TM) Phase 1 Clinical Trial 01.03.13 | 07:01 am
- 5 Under-$10 Stocks Primed to Trade Higher 12.20.12 | 12:12 pm
- 3 Stocks Rising on Unusual Volume 12.18.12 | 03:12 pm
Press Releases for ZGNX
- DURECT Announces Positive Results From Reldayâ¿¢ Phase 1 Clinical Trial - PR Newswire 01.03.13 | 07:01 am
- Fast-Acting Migraine Treatment Highlighted During National Migraine Awareness Month - PR Newswire 06.06.11 | 08:06 am
Partner Headlines for ZGNX
- Zogenix Says FDA Panel Will Review Zohydro on Dec. 7th - Benzinga 11.08.12 | 09:11 am
- 3 Best Biotech Stocks For This Week (Part V) - Seeking Alpha 10.08.12 | 09:10 am
- Healthcare Business Review: Sarepta Shoots Into Outer SPACE, Roche Gets GOOD News - Wall St. Cheat Sheet 07.25.12 | 08:07 am
- Earnings Preview: Covidien - Analyst Blog - Zacks 07.23.12 | 10:07 am
- Healthcare Biz Review: Vivus' Second TRY, Intuitive Surgical's PROSPECTS - Wall St. Cheat Sheet 07.16.12 | 12:07 pm
- Benzinga's Microcap Movers for Friday July 13, 2012 - Benzinga 07.14.12 | 04:07 pm
- Company News for March 12, 2012 - Corporate Summary - Zacks 03.12.12 | 10:03 am
- Zogenix: Smart Biotech Buy Before Earnings - Seeking Alpha 03.05.12 | 07:03 am
- Nupathe's Zelrix Going Down A Path With Multiple Headwinds - Seeking Alpha 12.09.11 | 09:12 am
- Biotech Catalysts for Third Quarter - Seeking Alpha 06.24.11 | 06:06 pm
